<DOC>
	<DOCNO>NCT02694952</DOCNO>
	<brief_summary>Interventional , individually randomize , double ( e.g . investigator participant ) blind , parallel two-arm , non-inferiority trial ass efficacy EchiTabPlus-ICP compare FAV-Africa treatment snakebite envenoming .</brief_summary>
	<brief_title>Non-inferiority Trial Two Snake Antivenoms CAR ( PAVES )</brief_title>
	<detailed_description>The study design randomize , double-blind , non-inferiority trial among patient suffer envenom follow snakebite Paoua , Central African Republic . The primary aim study assess non-inferiority EchiTabPlus-ICP compare FAV-Africa , prevent composite primary endpoint consist death cause , need blood transfusion need third dose antivenom . A total 196 patient individually randomize 1:1 ratio receive FAV-Africa EchiTabPlus-ICP . The first dose intervention antivenom administer study enrollment , need dos judge clinical exam 20 minute WBCT , follow protocol . All necessary medical care provide per routine Paoua Prefectural Hospital . Study followup surveillance adverse event serious adverse event continue 28 day initial dose antivenom . Unique identification number allocate individual independent study team use computer-generated random number list use permuted block random size . Block size disclose reduce predictability random sequence ensure allocation concealment . The Site Principal Investigator oversee randomization give set sequentially numbered silver coat booklet . The Site Principal Investigator instruct assign next sequential randomization code note booklet eligible participant ( ) enrol . Study antivenoms prepare unblinded study pharmacist , provide clinical staff identical presentation . Group assignment remain concealed study personnel , investigator , participant entire study period . The Data Safety Monitoring Board ( DSMB ) also mask group assignment . The DSMB remain masked unless otherwise deem necessary DSMB member safety related issue . Investigators conduct final analysis remain mask group assignment end analysis .</detailed_description>
	<mesh_term>Snake Bites</mesh_term>
	<mesh_term>Antivenins</mesh_term>
	<criteria>present within 72 hour snakebite sign symptom grade 2 envenoming ( oedema beyond elbow knee , bleed site bite , bleed gum hematuria ) grade 3 envenoming ( oedema shoulder hip , serious bleed epistaxis , hemoptysis , gastrointestinal bleeding ) lack coagulation blood 20 minute dry vacutainer tube ( abnormal 20 minute WBCT ) know allergy horse heterologous protein equine origins pregnancy receive antivenom since snakebite</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>